Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenomics and drug development.

Yingying Guo1, Steven Shafer, Paul Weller

  • 1Roche Palo Alto, Department of Genetics and Genomics, S3-1, 3431 Hillview Ave, Palo Alto, CA 94304, USA.

Pharmacogenomics
|November 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accelerating scientific discovery with Co-Scientist.

Nature·2026
Same author

Genetic Diagnosis and Discovery Enabled by Large Language Models.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Natural metal-containing nanoparticles as an important form of metals in their biogeochemical cycle and biological effect.

Water research·2026
Same author

Prevalence, Characterization and Genetic Diversity of <i>Listeria monocytogenes</i> in Ready-to-Eat Raw Salmon (<i>Salmo salar</i>) and Trout (<i>Oncorhynchus mykiss</i>) Products.

Foods (Basel, Switzerland)·2026
Same author

A Murine Database of Structural Variants Identifies A Candidate Gene for a Spontaneous Murine Lymphoma Model.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Pemphigoid Gestationis Refractive to Dual Systemic Therapy Treated With Dupilumab.

The Australasian journal of dermatology·2026
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
Same journal

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Pharmacogenomics·2026
See all related articles

Pharmacogenomic information improves drug efficacy and reduces toxicity through genetically-guided dosing. Identifying genetic factors is crucial for routine clinical pharmacogenomic testing and personalized medicine.

Area of Science:

  • Pharmacogenomics
  • Clinical Pharmacology
  • Computational Genetics

Background:

  • Pharmacogenomic information is expected to significantly impact drug development and personalized medicine.
  • Quantitative modeling is lacking to guide the clinical application of pharmacogenomics.
  • Identifying genetic variables influencing drug response is essential for routine clinical use.

Purpose of the Study:

  • To quantitatively model the utilization of pharmacogenomic information in clinical practice.
  • To demonstrate the benefits of genetically-guided dose adjustment strategies.
  • To highlight the need for identifying genetic factors affecting drug disposition and action.

Main Methods:

  • Utilized a quantitative model to assess the impact of pharmacogenomic information.

Related Experiment Videos

  • Reviewed existing literature on genetic variables affecting drug response.
  • Considered a murine haplotype-based computational genetic analysis method.

    • Main Results:

    • Genetically-guided dose adjustment strategies in clinical trials increase drug efficacy.
    • Genetically-guided dose adjustment strategies in clinical trials reduce drug toxicity.
    • Limited information currently exists on genetic factors for most common medications.

    Conclusions:

    • Pharmacogenomic information, when applied through genetically-guided dosing, enhances clinical trial outcomes.
    • Further research is needed to identify genetic factors influencing drug pharmacokinetics and pharmacodynamics.
    • Computational genetic analysis offers a potential strategy for identifying these critical genetic factors.